Antibacterial activity of cystobactamids with optimized A-rings and isopropoxy/hydroxyl-substituted E-ring, given as minimal inhibitory concentrations (MICs) in μg mL−1, and inhibitory activity against DNA gyrase in μMe.
![]() | |||||||
---|---|---|---|---|---|---|---|
Compound | R | MIC [μg mL−1] | EC gyrase IC50 [μM] | ||||
E. coli ΔtolCa | E. coli WTb | P. ae. ΔmexABa | P. ae. WTc | S. aureus d | |||
Reference 78 |
![]() |
0.125 | 0.5 | 1 | >64 | 0.05 | 0.2 |
79 |
![]() |
≤0.03 | 0.25 | 1 | 2 | ≤0.03 | 0.6 |
80 |
![]() |
≤0.03 | 0.06 | 0.5 | >64 | ≤0.03 | nd |
81 |
![]() |
0.06 | 0.125 | 2 | >64 | 0.06 | nd |
82 |
![]() |
≤0.03 | 0.125 | 0.25 | 1 | 0.06 | 0.2 |
Strain provided by collaborators, see ESI.
DSM-1116.
PA14.
ATCC29213.
nd = not determined, P. ae. = P. aeruginosa.